Article
Preemptive Bone Marrow Transplantation for FANCD1/BRCA2.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Oct 2015
Khan Nicholas E, Rosenberg Philip S, Lehmann Harold P, Alter Blanche P
Abstract excerpt
Children with biallelic mutations in FANCD1/BRCA2 are at uniquely high risks of leukemia and solid tumors. Preemptive bone marrow transplantation (PE-BMT) has been proposed to avoid the development of leukemia, but empirical study of PE-BMT is unlikely because of the rarity of these children and the unknown benefit of PE-BMT. We used survival analysis to estimate the risks of leukemia and the expected survival if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
